INTRODUCTION
Hereditary breast and ovarian cancer syndrome is an inherited cancer susceptibility syndrome. The hallmarks of this syndrome are multiple family members with breast or/and ovarian cancer, the presence of both breast and ovarian cancer in a single individual, and early age of breast cancer onset (LU et al. 2009 ).
DOI: 10.2478/v10107-009-0006-1 Expression of TopBP1 50 Breast and ovarian cancers are among the most common malignancies of women in Western countries. About 5 -10% of the cases are considered familial, and 40 -50% of them can currently be explained by mutations in two main susceptibility genes, BRCA1 and BRCA2. Of the remaining cases no more than 5% are caused by defects in other studied genes, such as TP53, PTEN, ATM and CHK2 (KARPPINEN et al. 2006; EASTON 1999) . TopBP1 (topoisomerase IIβ binding protein 1) displays structural as well as functional similarities with BRCA1, and both proteins have been suggested to function partly in the same cellular processes (KARPPINEN et al. 2006) . Based on its biological significance KARPPINEN et al. (2006) suggested that TopBP1 is a plausible susceptibility gene for hereditary breast and/or ovarian cancer. Aberrant expression of TopBP1 may be involved in the deregulation of processes controlled by this protein and have pathological consequences. The aim of this study was to investigate the expression of TopBP1 at the mRNA level in hereditary breast cancer.
MATERIALS AND METHODS

Sample collection
Samples of 94 hereditary breast cancers were obtained from patients (age range 28 -67 years) undergoing surgery for breast neoplasms in Polish Mather's Memorial Hospital, Poland. The inclusion criteria were: (1) at least one first-degree relative with breast cancer, regardless of age, or (2) breast cancer diagnosed below 40 years of age. None of the patient received neoadjuvant endocrine therapy, chemotherapy and radiotherapy. The pathological evaluation report was obtained for each patient (Table 1) . Immediately after resection, samples of breast cancer tissue were fixed in 10% neutral buffered formalin and embedded in paraffin blocks following standard histological protocols. For our studies tissue sections were cut from the blocks with a microtome blade, extra paraffin was removed, and tissue sections was placed in a 1.5-ml microcentrifuge tube. were resuspended in 500 µl of digestion buffer (10 mM NaCl, 500 mM Tris-HCl, pH 8.0, 25 mM EDTA, 1% SDS) and 1 mg/ml proteinase K was added. Sections were incubated at 45°C overnight. Prior to RNA purification, in same samples we inactivated proteinase K at 97°C for 10 min. The digested samples were extracted using TRI Reagent (Sigma Aldrich, USA) according to manufacturer's protocol.
RNA was eluted in 20 µl RNase-free water, quantified by spectrophotometry at 260
nm and stored at -20°C. RNA with a 260/280 nm ratio in range 1.8 -2.0 was considered high quality. First-strand cDNA was synthesized from each RNA pool using PCR Kit ver. 3.0 (Takara Bio Inc. Japan) according to the manufacturer's instructions. Briefly, 1 µg RNA was combined with 2.5 pmol of oligo dT-adapter primer, 4 µl of 25 mM MgCl 2 , 2 µl 10 x RNA PCR buffer, 2 µl of 10 mM dNTP mixture, 20 units of RNase inhibitor, 5 units of AMV Reverse Transcriptase XL, and
RNase-free water to total volume of 20 µl. The reaction took place at 42°C for 30 min, followed by 95°C for 5 min and 5°C for 5 min in a GeneAmp PCR System 9700 (Perkin-Elmer Co, USA). cDNA was stored at -20°C.
RT-PCR
One microliters of cDNA sample was used as a substrate for PCR reaction in a 20 µl volume with 1 µM of forward and reverse primers, 0.2 mM of each dNTP, 
Statistical analysis
All data are presented as mean ± SEM. Because results obtained from RT-PCR were not normally distributed (Kolmogorov-Smirnov test), therefore nonparametric Mann-Whitney U-test (for two categories) and the Kruskal-Wallis test with post hoc multiple comparisons (for three categories) were used. Statistical significance was designated at P<0.05. (Fig. 2) . Amplification products were separated on the 8% polyacrylamide gel. T -TopBP1;
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G -GAPDH; M -molecular weight markers. JEON et al. 2007; KIM et al., 2005; KUMAGAI et al. 2006; LIU et al 2006; MORISHIMA et al. 2007; SCHMIDT et al 2008; YAMMANE et al. 2003) . TopBP1 is also involved in the process of mitosis in somatic cells and during meiotic recombination in germ cells REINI et al. 2004) . Most of TopBP1 does not colocalize at site of ongoing DNA replication in irradiated cells but is relocalized to stalled replication forks upon DNA damage. The involvement of TopBP1 in DNA replication is supported by the demonstration that incubation of an antibody against the sixth BRCT motif of TopBP1 inhibits replicative DNA synthesis in a in vitro HeLa cell nucleus replication assay (KIM et al. 2004; MAKINEMI et al. 2001) . TopBP1 can interact with human polymerase ε, checkpoint protein Rad9, Miz-1, E2F1, human papilliomavirus type 16 (HPV16) transcription/replication factor E2 (BONER et al. 2002; DONALDSON et al. 2007; DELACROIX et al. 2007; HEROLD et al. 2002; LIU et al. 2003 LIU et al. , 2004 LIU et al. , 2006 MAKINIEMI et al. 2001) . TopBP1 also participates in ATR activation in ATRIPdependent manner (BURROWS, ELLEDGE 2008; CIMPRICH, CORTEZ 2008; KUMAGAI et al. 2006; LEE et al. 2007 ). In addition to control DNA replication, TopBP1 is also required for cell survival. Inhibition of TopBP1 expression induces apoptosis.
TopBP1 is involved in several important aspects of regulation cell growth (LIU et al. 2003; YAMANE et al. 2002) . The aim of this study was investigate the transcript level of TopBP1 gene. Analysis of TopBP1 expression shown that tumor progression is accompanied by a decrease of TopBP1 mRNA level. Expression of TopBP1 is regulated by Rb/E2F1 and is induced when cells enter into S phase (LIU et al. 2004 (LIU et al. , 2009 YOSHIDA, INOUE 2004) . Therefore, disruption of Rb/E2F1 pathway can lead to overexpression of TopBP1 protein in breast cancers. In the other hand, TopBP1
regulates activity of E2F1 and overexpression of TopBP1 suppressed E2F1 transcriptional activity (LIU et al. 2003 (LIU et al. , 2004 (HO et al. 2001; KWON et al. 2009 ). However, regulation of TopBP1 expression will need to be studied.
